Back to search

Inhibition of lymphoma growth in vivo by combined treatment with hydroxyethyl starch deferoxamine conjugate and IgG monoclonal antibodies against the transferrin receptor.

Data up to Jan 2025

Published1995
Citations42
References24

Total Citations Per Year

Abstract

References (24)

In situ detection of mycoplasma contamination in cell cultures by fluorescent Hoechst 33258 stain

1977 • 1,743 citations

Rapid tumor penetration of a single-chain Fv and comparison with other immunoglobulin forms.

1992 • 824 citations

Mechanisms of heterogeneous distribution of monoclonal antibodies and other macromolecules in tumors: significance of elevated interstitial pressure.

1988 • 703 citations

Effects of a single course of deferoxamine in neuroblastoma patients.

1990 • 197 citations

Studies in Desferrioxamine and Ferrioxamine Metabolism in Normal and Iron‐Loaded Subjects

1979 • 189 citations

Characterization of a carcinogen‐induced murine B lymphocyte cell line of C3H/eB origin

1977 • 169 citations

Monoclonal Anti-Idiotype Antibodies Against the Murine B Cell Lymphoma 38C13: Characterization and Use as Probes for the Biology of the Tumor In Vivo and In Vitro

1985 • 115 citations

Combinations of anti-transferrin receptor monoclonal antibodies inhibit human tumor cell growth in vitro and in vivo: evidence for synergistic antiproliferative effects.

1990 • 111 citations

Exposure of K562 cells to anti-receptor monoclonal antibody OKT9 results in rapid redistribution and enhanced degradation of the transferrin receptor.

1986 • 97 citations

Modulation of transferrin receptor expression and function by anti-transferrin receptor antibodies and antibody fragments

1989 • 75 citations

Mechanisms of growth inhibition by anti-transferrin receptor monoclonal antibodies.

1986 • 74 citations

Desferrioxamine Treatment Prevents Chronic Islet Allograft Damage

1986 • 52 citations

Use of nude mouse xenografts as preclinical drug screens: in vivo activity of established chemotherapeutic agents against melanoma and ovarian carcinoma xenografts.

1987 • 48 citations

Effects of monoclonal antibodies that block transferrin receptor function on the in vivo growth of a syngeneic murine leukemia.

1987 • 43 citations

Combination Iron Depletion Therapy

1989 • 40 citations

Inhibition of hematopoietic tumor growth by combined treatment with deferoxamine and an IgG monoclonal antibody against the transferrin receptor: evidence for a threshold model of iron deprivation toxicity.

1992 • 39 citations

Role of the transferrin receptor in lymphocyte growth: a rat IgG monoclonal antibody against the murine transferrin receptor produces highly selective inhibition of T and B cell activation protocols.

1987 • 35 citations

The metabolism of desferrioxamine B and ferrioxamine B

1967 • 34 citations

Synergistic inhibition of lymphoid tumor growth in vitro by combined treatment with the iron chelator deferoxamine and an immunoglobulin G monoclonal antibody against the transferrin receptor

1990 • 29 citations

Anti-idiotypic antibodies recognizing stable epitopes limit the emergence of idiotype variants in a murine B cell lymphoma.

1990 • 29 citations

Structural characteristics of the mouse transferrin receptor

1984 • 28 citations

D-CECaT

1993 • 25 citations

Antigen forks: bispecific reagents that inhibit cell growth by binding selected pairs of tumor antigens

1994 • 5 citations

Acute Resuscitation and Antioxidant Therapy

1993 • 1 citations

Cited By (0)

Loading...
Inhibition of lymphoma growth in vivo by combined treatment with hydroxyethyl starch… (1995) – PubMed | Metascience Observatory Explorer